Literature DB >> 29538718

Long-Term Outcomes After Gamma Knife Radiosurgery for Benign Meningioma: A Single Institution's Experience With 424 Patients.

Youngbeom Seo1, Dong Gyu Kim1, Jin Wook Kim1, Jung Ho Han2, Hyun-Tai Chung1, Sun-Ha Paek1.   

Abstract

BACKGROUND: Gamma knife radiosurgery (GKRS) is recognized as an important treatment modality for meningioma.
OBJECTIVE: To analyze the long-term outcomes in meningioma patients treated with GKRS to determine the risk factors related to treatment failure and peritumoral edema (PTE) development.
METHODS: Between 1998 and 2010, 770 consecutive patients were treated with GKRS for intracranial meningioma. After the exclusion of patients with follow-up periods of less than 5 yr and those with neurofibromatosis, multiple meningiomas, nonbenign meningioma, or radiotherapy, a total of 424 patients were enrolled in this study. The median follow-up duration was 92 mo. The median tumor volume was 4.35 cm3, and the median marginal dose was 14 Gy.
RESULTS: The overall local tumor control rate was 84%. The actuarial tumor control rates were 91.7% and 78.9% at 5 and 10 yr, respectively. The tumor control rate of a radiologically diagnosed tumor was higher than that of a grade I tumor (82% vs 70.1% at 10 yr, P = .001). In multivariate analysis, factors associated with tumor progression were female sex (hazard ratio: 0.5, P = .025) and a previous history of craniotomy (hazard ratio: 1.9, P = .009). Symptomatic PTE was identified in 36 (8.5%) patients, and the factor associated with poor PTE was the presence of PTE before GKRS (odds ratio: 4.6, P < .001). Permanent complication rate was 4%.
CONCLUSION: GKRS appears to be an effective treatment modality for meningioma with long-term follow-up. However, the identification of delayed tumor progression in our study suggests that extended follow-up data should be collected after GKRS.

Entities:  

Mesh:

Year:  2018        PMID: 29538718     DOI: 10.1093/neuros/nyx585

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  7 in total

1.  Malignant transformation of WHO grade I meningiomas after surgery or radiosurgery: systematic review and meta-analysis of observational studies.

Authors:  Satoshi Nakasu; Akifumi Notsu; Kiyong Na; Yoko Nakasu
Journal:  Neurooncol Adv       Date:  2020-10-16

Review 2.  Laser interstitial thermal therapy in neuro-oncology applications.

Authors:  Christopher S Hong; Adam J Kundishora; Aladine A Elsamadicy; Veronica L Chiang
Journal:  Surg Neurol Int       Date:  2020-08-08

3.  Linear Accelerator-Based Radiosurgery of Grade I Intracranial Meningiomas.

Authors:  Sara Alatriste-Martínez; Sergio Moreno-Jiménez; Guillermo A Gutiérrez-Aceves; José de Jesús Suárez-Campos; Olivia Amanda García-Garduño; Alejandro Rosas-Cabral; Miguel Ángel Celis-López
Journal:  World Neurosurg X       Date:  2019-03-07

4.  Stereotactic radiosurgery of benign brain tumors in elderly patients: evaluation of outcome and toxicity.

Authors:  Daniel Rueß; Vera Weyer; Juman Tutunji; Stefan Grau; Martin Kocher; Mauritius Hoevels; Harald Treuer; Christian Baues; Maximilian I Ruge
Journal:  Radiat Oncol       Date:  2020-12-09       Impact factor: 3.481

5.  Primary versus postoperative gamma knife radiosurgery for intracranial benign meningiomas: a matched cohort retrospective study.

Authors:  Junyi Fu; Jiamin Zeng; Minyi Huang; Shunyao Liang; Yong He; Longchang Xie; Yinhui Deng; Jinxiu Yu
Journal:  BMC Cancer       Date:  2022-02-24       Impact factor: 4.430

6.  Meningioma Treated With Hypofractionated Stereotactic Radiotherapy Using CyberKnife®: First in the United Arab Emirates.

Authors:  Nandan M Shanbhag; Christos Antypas; Abdul K Msaddi; Sinead Catherine Murphy; Teekendra T Singh
Journal:  Cureus       Date:  2022-02-01

7.  Normofractionated stereotactic radiotherapy versus CyberKnife-based hypofractionation in skull base meningioma: a German and Italian pooled cohort analysis.

Authors:  Conti Alfredo; Senger Carolin; Acker Güliz; Kluge Anne; Pontoriero Antonio; Cacciola Alberto; Pergolizzi Stefano; Germanò Antonino; Badakhshi Harun; Kufeld Markus; Meinert Franziska; Nguyen Phuong; Loebel Franziska; Vajkoczy Peter; Budach Volker; Kaul David
Journal:  Radiat Oncol       Date:  2019-11-12       Impact factor: 3.481

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.